Trial Details

COMPLETED
Basic Information
Clinical ID c1321
Identifier NCT02531126
Trial Title An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: RPC1063
Participant Information
Sponsor Celgene
City Tucson
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2015-12-02
Primary Completion Date 2024-12-19
Completion Date 2024-12-19